This paper describes the effect of angiotensinconverting enzyme (ACE) inhibitors on the electrical properties of the heart, particularly the effect of these drugs on heart cell coupling and impulse propagation and the possible implications for the generation of malignant ventricular arrhythmias. The hyperpolarising Keywords: enalapril; hyperpolarisation; heart; pig; Na-KATPase Evidence has been presented that the renin-angiotensin system influences the heart contractility, 1 the impulse conduction and excitability.
Evidence has been presented that the renin-angiotensin system influences the heart contractility, 1 the impulse conduction and excitability. 2 The major effects of angiotensin II on heart functions are accomplished through the activation of angiotensin II AT 1 receptors which have been identified in cultured cardiac myocytes 3 as well as on the heart muscle of different species including humans. 4 The presence of a cardiac rennin-angiotensin system has been supported by several observations. 5, 6 Angiotensin I (Ang I), for instance, is converted to angiotensin II in the isolated and perfused rat heart 7 and Ang II is synthesised inside the cardiac myocytes. 4 It has been shown that enalapril, an angiotensinconverting enzyme (ACE) inhibitor, decreases the intracellular resistance and increases the conduction velocity in the heart of adult rats and cardiomyopathic hamsters at an advanced stage of the disease. 8, 9 Angiotensin II, applied locally to endocardial fibres in the failing heart, causes an appreciable increase in the dispersion of action potential duration, which is known to be an important mechanism of cardiac arrhythmias. 10 Recent studies, performed on Ang II type 1a receptor knockout mice, showed that AT 1 receptors are involved in the occurrence of reperfusion arrhythmias. 11 Furthermore, increased ACE activity has been reported in humans with chronic atrial fibrillation. 12 The activation of a cardiac renin-angiotensin system in the heart which occurs during heart failure, leads to an increment in the intracardiac levels of Ang II with consequent decrease of impulse conduction and facilitation of reentry. Enalapril, by inhibiting the convertion of Ang I to Ang II in plasma as well as in the heart, increments the cell coupling and prevents the morphologic and electrophysiologic remodelling, an important cause of malignant ventricular arrhythmias and sudden death.
The improvement of impulse propagation seen with enalapril in isolated cardiac muscle is related to the increase in cell coupling as well as to the increase in membrane potential. 2, 9 However, no information is available on the mechanism of the hyperpolarising action of enalapril and so this has been the subject of our recent investigation. For this, muscle trabeculae and Purkinje fibres were isolated from right and left ventricles of a pig's heart obtained from a local slaughterhouse. Dissected preparations were gently held at the bottom of a Perspex chamber through which the Tyrode solution (at 37°C) flowed continuously. Conventional intracellular microelectrodes were used to record the membrane potential.
Measurements of transmembrane resting and action potential performed on muscle trabeculae isolated from the left ventricle of the pig's heart indicated that enalapril maleate (10 −7 M) administered to bath solution, caused a hyperpolarisation of 10.2 ± 2 mV (P Ͻ 0.05; n = 25) within 10 min ( Figure 1 ). The effect of enalapril on membrane potential was dose-dependent (see Figure 1 ).
We also investigated the possible role of the sodium-potassium pump on the increment of membrane potential elicited by enalapril. There is general agreement that the extracellular potassium concentration is an activator of Na-K-ATPase and that the removal of potassium from bath solution inhibits the Na-K pump. Indeed, the pump current is highly dependent on K o with a Hill coefficient of 1.94. 13 To investigate this hypothesis the muscle trabeculae were immersed in K-free solution and the membrane potential was continuously monitored. As shown in Figure 2 the membrane potential was reduced by K-free solution reaching a new steady state level (52 ± 2.4 mV) within 20 min. The reestablishing of the normal extracellular K concentration (5.4 mM) led to a transient hyperpolarisation of 6.4 mV (beyond the normal resting potential) that lasts 18 min and then the resting potential returned to the control level. [14] [15] [16] In the second phase of the same experiment the muscle was again exposed to K-free solution and as soon as the membrane potential reached a new steady level, the muscle was perfused with normal Krebs solution (K o = 5.4 mM) to which enalapril (10 −7 M) was added. As shown in Figure 2 the hyperpolarisation induced by normal Krebs solution in presence of enalapril, was larger than that achieved by the re-establishment of normal Krebs solution alone. In other experiments in which the muscles were kept in K-free solution, the administration of enalapril to this solution caused no hyperpolarisation of the muscle fibres (see Figure 2) .
The influence of ouabain on the hyperpolarising action of enalapril was also investigated. For this, the membrane potential was recorded under control conditions and then ouabain (10 −6 M) was added to the bath and the membrane potential was monitored. As shown in Figure 3 , ouabain reduced the resting potential by 65 ± 3.2% within 30 min (P Ͻ 0.05; n = 25). As soon as the resting potential reached a new steady level in presence of ouabain, enalapril was added to the bath containing ouabain (10 −6 M) and the resting potential was again monitored. Figure 3 indicates that the administration of enalapril to ouabain solution, abolished the hyperpolarisation induced by enalapril. In experiments in which enalapril (10 −7 M) was added first to the bath the ulterior administration of ouabain (10 −6 M) to the enalapril solution did not prevent the depolarisation induced by ouabain (10 −6 M) (not shown). In isolated Purkinje fibres beating spontaneously, enalapril (10 −7 M) added to the bath reduced the slope of diastolic depolarisation and incremented the amplitude of the action potential (Figure 4) . The effect of enalapril was seen within 20[T}min of its administration to the bath and was completely reversible. No significant change in action potential duration or the maximal diastolic potential was seen with enalapril but the amplitude of the action potential was increased by 29 ± 3% (P Ͻ 0.05).
The present results indicate that enalapril hyperpolarises the cell membrane in the pig ventricular muscle and reduces the slope of diastolic depolarisation in isolated Purkinje fibres. The increment in membrane potential elicited by enalapril in pig trabeculae seems related to activation of the sodiumpotassium pump because: (a) ouabain blocks the hyperpolarising action of enalapril; (b) in fibres immersed in potassium-free solution which is known to inhibit the sodium-potassium pump 14, 17, 18 enalapril is unable to hyperpolarise the cardiac fibre; (c) the hyperpolarisation induced by normal Krebs solution in trabeculae previously treated with K-free solution was incremented by enalapril; and (d) enalapril increases the activity of Na-KATPase in intact myocytes isolated from a rabbit's heart. 19 Concurrently with the increase in resting potential, an increase in amplitude and duration of the action potential was seen in trabeculae exposed to enalapril supporting the view that the ACE inhibitor improves impulse conduction in cardiac muscle.
Because the fall in membrane potential produced by ouabain was not influenced by previous administration of enalapril it is reasonable to conclude that enalapril is not acting directly on the Na-K-ATPase. Our experiments performed in membrane isolated from crude extract of the ventricular muscle indicated no effect of enalapril on Na-KATPase (Corey and De Mello, unpublished) . It is known that NaKATPase activity is modulated by many intracellular signalling pathways including protein kinases, phospholipases and phosphatases. Direct phosphorylation of the Na-KATPase, for instance, is one of the mechanisms by which protein kinase C regulates the sodium pump activity. 19, 20 Although it is known that enalapril alters the 1¡&28;2 diacylglycerol production in the heart of spontaneously hypertensive rats, 21 further studies are needed to clarify the intimate mechanism by which enalapril activates the Na-KATPase.
The possibility that part of the hyperpolarising action of enalapril be due to an increase in membrane potassium conductance seems unlikely because: (a) the administration of ouabain or the exposure of the tissue to K-free solution abolished completely the hyperpolarisation induced by enalapril; and (b) previous studies indicated no effect of ACE inhibitors on membrane potassium current in normal or in hypertrophied ventricular myocytes. 22 The implications of the present results to clinical cardiology are various. The increment of membrane potential elicited by enalapril, for instance, enhances the impulse conduction in partially depolarised fibres and prevents slow conduction and re-entry, an important cause of cardiac arrhythmias. On the other hand, the decrease in diastolic depolarisation elicited by enalapril in isolated Purkinje fibres, is of particular interest because it indicates, for the first time, that the ACE inhibitor reduces spontaneous rhythmicity. It is known that the activation of I f and the deactivation of I k plays an important role during the initial phase of the diastolic depolarisation and that later on I CaL and I CaT takes over. Because previous studies 23 indicated that captopril, another ACE inhibitor, reduces the I CaL in cardiac muscle, it is reasonable to think that the reduction in the slope of diastolic depolarisation elicited by enalapril be, at least in part, related to the decline in calcium current. Further studies will be needed to clarify this point. The decrease in the slope of diastolic depolarisation elicited by enalapril together with the increment in cardiac refractoriness 24 supports the view that the drug has antiarrhythmic properties.
